Technology | Treatment Planning | October 24, 2018

Siris Medical Releases PlanMD Decision Support Software

New software introduces real-time prescriptive contouring to enable faster, smarter radiation therapy treatment planning and better outcomes

Siris Medical Releases PlanMD Decision Support Software

October 24, 2018 — Siris Medical Inc. announced the release of its new artificial intelligence (AI) treatment decision-support system for use in radiation oncology. The new PlanMD software enables radiation oncology clinical teams to leverage patient data and artificial intelligence to efficiently empower their treatment decisions. The software is the first and only tool, according to the company, that enables the physician to see the effect of editing contours in real time, without re-optimizing or replanning.

PlanMD complements Siris Medical’s QuickMatch software, which accelerates the treatment planning process by using AI to quickly identify the most similar cases previously treated to inform planning decisions and help reduce dose to critical structures. Siris Medical President and CEO Colin Carpenter, Ph.D., said the software has been shown to enable clinical teams to save up to 70 percent of the time required to plan treatment.

This announcement follows a recent publication, “Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making,” in the Journal of Radiotherapy and Oncology in December 2017.1 This study demonstrates the ability of the QuickMatch software to draw upon historical clinical insights for patient-specific decision making. The study was a collaborative effort between the University of California San Francisco (UCSF), University of Pennsylvania, University of Maryland and Siris Medical.

For more information: www.siris-medical.com

Reference

1. Valdes G., Simone C.B., Chen J., et al. Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making. Journal of Radiotherapy and Oncology, Nov. 20, 2017. https://doi.org/10.1016/j.radonc.2017.10.014

Related Content

Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Novel scanners may open door for prognostic assessment in patients receiving cochlear implants

Iva Speck, MD, explains research showing that novel, fully digital, high-resolution positron emission tomography/computed tomography imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment. The research is featured in The Journal of Nuclear Medicine (read more at http://jnm.snmjournals.org/content/current). Video courtesy of Iva Speck, University Hospital Freiburg, Germany.

News | PET-CT | March 26, 2020
March 26, 2020 — Novel, fully digital, high-resolution...
Instant triage capability could potentially speed up diagnosis of COVID-19 individuals and ensure resources allocated properly.
News | Artificial Intelligence | March 23, 2020
March 23, 2020 — behold.ai announced that its artificial intellige